GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 66 filers reported holding GEMINI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $562,000 | -56.4% | 342,532 | -55.1% | 0.00% | -100.0% |
| Q2 2022 | $1,288,000 | +72.9% | 762,163 | +42.1% | 0.00% | – |
| Q1 2022 | $745,000 | -49.5% | 536,202 | +5.7% | 0.00% | -100.0% |
| Q4 2021 | $1,476,000 | -47.4% | 507,328 | -27.0% | 0.00% | 0.0% |
| Q3 2021 | $2,807,000 | +69.6% | 694,707 | +171.6% | 0.00% | 0.0% |
| Q2 2021 | $1,655,000 | -63.0% | 255,742 | -22.5% | 0.00% | -66.7% |
| Q1 2021 | $4,472,000 | – | 330,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 2,435,125 | $3,385,000 | 4.74% |
| Foresite Capital Management V, LLC | 2,435,125 | $3,385,000 | 1.38% |
| Atlas Venture Life Science Advisors, LLC | 5,254,365 | $7,304,000 | 0.92% |
| Orbimed Advisors | 5,826,224 | $8,098,000 | 0.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,372,267 | $3,297,000 | 0.10% |
| Boxer Capital, LLC | 1,300,000 | $1,807,000 | 0.09% |
| Ikarian Capital, LLC | 443,096 | $615,000 | 0.08% |
| HARVARD MANAGEMENT CO INC | 250,000 | $348,000 | 0.04% |
| PURA VIDA INVESTMENTS, LLC | 496,120 | $690,000 | 0.02% |
| Marquette Asset Management, LLC | 66,269 | $92,000 | 0.02% |